# Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery

> **NCT01867606** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 58 (actual)

## Conditions studied

- Female Reproductive Cancer

## Interventions

- **BIOLOGICAL:** serum-derived bovine immunoglobulin protein isolate
- **OTHER:** placebo
- **OTHER:** laboratory biomarker analysis
- **OTHER:** quality-of-life assessment
- **OTHER:** questionnaire administration

## Key facts

- **NCT ID:** NCT01867606
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-04
- **Primary completion:** 2015-11-21
- **Final completion:** 2015-11-21
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01867606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01867606, "Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01867606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*